Evidence map›Paper›PMID 23299977›Full record

ArticleGenome research2013

A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.

Matthew T G Holden, Li-Yang Hsu, Kevin Kurt, Lucy A Weinert, Alison E Mather, Simon R Harris, Birgit Strommenger, Franziska Layer, Wolfgang Witte, Herminia de Lencastre and 27 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 261 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
261citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

261 citing papers in PubMed, 1 synthesis or guideline pooled it, 445 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Antibacterial Potential ofFoods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Molecular Variation of Methicillin-resistantRecent patents on biotechnology · 2026
    Article
  12. Review
  13. Transition ofbioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Observational
  16. Antibiotics (Basel, Switzerland) · 2025
    Review
  17. Article
  18. Article
  19. Methicillin-sensitiveMicrobial genomics · 2025
    Article
  20. Article

201 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 16 institutions in 10 countries.

Matthew T G HoldenThe Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB19 1SA, United Kingdom.
Li-Yang Hsu
Kevin Kurt
Lucy A Weinert
Alison E Mather
Simon R Harris
Birgit Strommenger
Franziska Layer
Wolfgang Witte
Herminia de Lencastre
Robert Skov
Henrik Westh
Helena Zemlicková
Geoffrey Coombs
Angela M Kearns
Robert L R Hill
Jonathan Edgeworth
Ian Gould
Vanya Gant
Jonathan Cooke
Giles F Edwards
Paul R McAdam
Kate E Templeton
Angela McCann
Zhemin Zhou
Santiago Castillo-Ramírez
Edward J Feil
Lyndsey O Hudson
Mark C Enright
Francois Balloux
David M Aanensen
Brian G Spratt
J Ross Fitzgerald
Julian Parkhill
Mark Achtman
Stephen D Bentley
Ulrich Nübel
Imperial College London · GBWellcome Sanger Institute · GBRobert Koch Institute · DEUniversity College Cork · IEUniversity of Bath · GBUniversity of Edinburgh · GBAberdeen Royal Infirmary · GBEdinburgh Royal Infirmary · GBGuy's and St Thomas' NHS Foundation Trust · GBNational Institute of Public Health · JPNHS Greater Glasgow and Clyde · GBRockefeller University · USRoyal Perth Hospital · AUStatens Serum Institut · DKUniversity College Hospital · GBUniversity of Copenhagen · DK

Funding

Biotechnology and Biological Sciences Research Council BB/I013873/1Chief Scientist Office CZB/4/717Medical Research Council G0800777Medical Research Council MR/K001744/1PHS HHS 2 RO1I457838-12Wellcome TrustWellcome Trust 089472Wellcome Trust 098051
6 · The paper itself

Abstract

The widespread use of antibiotics in association with high-density clinical care has driven the emergence of drug-resistant bacteria that are adapted to thrive in hospitalized patients. Of particular concern are globally disseminated methicillin-resistant Staphylococcus aureus (MRSA) clones that cause outbreaks and epidemics associated with health care. The most rapidly spreading and tenacious health-care-associated clone in Europe currently is EMRSA-15, which was first detected in the UK in the early 1990s and subsequently spread throughout Europe and beyond. Using phylogenomic methods to analyze the genome sequences for 193 S. aureus isolates, we were able to show that the current pandemic population of EMRSA-15 descends from a health-care-associated MRSA epidemic that spread throughout England in the 1980s, which had itself previously emerged from a primarily community-associated methicillin-sensitive population. The emergence of fluoroquinolone resistance in this EMRSA-15 subclone in the English Midlands during the mid-1980s appears to have played a key role in triggering pandemic spread, and occurred shortly after the first clinical trials of this drug. Genome-based coalescence analysis estimated that the population of this subclone over the last 20 yr has grown four times faster than its progenitor. Using comparative genomic analysis we identified the molecular genetic basis of 99.8% of the antimicrobial resistance phenotypes of the isolates, highlighting the potential of pathogen genome sequencing as a diagnostic tool. We document the genetic changes associated with adaptation to the hospital environment and with increasing drug resistance over time, and how MRSA evolution likely has been influenced by country-specific drug use regimens.

Indexed as

Genome, BacterialCluster AnalysisDrug Resistance, BacterialGenomicsGenotypeHumansMethicillin-Resistant Staphylococcus aureusPandemicsPhylogenyPhylogeographyStaphylococcal InfectionsUnited Kingdom

Identifiers

PMID23299977
PMCPMC3613582
OpenAlexW2134529369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.